Who are in the management team of Crinetics Pharmaceuticals, Inc.?

Jun 22 2025 10:39 PM IST
share
Share Via
As of March 2022, Crinetics Pharmaceuticals, Inc.'s management team includes Dr. R. Scott Struthers as CEO, along with several independent directors, including Dr. Wendall Wierenga as Chairman.
As of March 2022, the management team of Crinetics Pharmaceuticals, Inc. includes the following individuals:

- Dr. Wendall Wierenga, who serves as the Independent Chairman of the Board.
- Dr. R. Scott Struthers, who is the President, Chief Executive Officer, and a Director.
- Dr. Camille Bedrosian, who is an Independent Director.
- Mr. Matthew Fust, who is also an Independent Director.
- Dr. Stephen Kaldor, another Independent Director.
- Mr. Weston Nichols, who serves as an Independent Director.
- Ms. Stephanie Okey, who is an Independent Director.

In summary, the management team consists of a mix of independent directors and executive leadership, with Dr. R. Scott Struthers as the CEO.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News